Literature DB >> 17853021

Elastase deposits in the kidney and urinary elastase excretion in patients with glomerulonephritis--evidence for neutrophil involvement in renal injury.

Jakub Kuźniar1, Tomasz J Kuźniar, Zofia Marchewka, Jadwiga Lembas-Bogaczyk, Jerzy Rabczyński, Wacław Kopeć, Marian Klinger.   

Abstract

OBJECTIVE: Elastase is a key proteolytic enzyme released during polymorphonuclear leukocyte degranulation. There are abundant data of elastase involvement in the development of injury in experimental models of glomerulonephritis (GN), but scant direct evidence of its involvement in human primary GN. The aims of this study were to determine the immunolocalization of elastase deposits in kidney biopsy specimens from patients with primary idiopathic GN, to attempt to correlate the distribution and intensity of deposits with urinary elastase excretion, and to determine clinical markers of renal injury in several types of primary idiopathic GN.
MATERIAL AND METHODS: The immunohistochemical localization and intensity of elastase deposits in kidney biopsies, the urinary excretion of leukocyte elastase, and proteinuria and serum creatinine levels were evaluated in 23 patients with primary GN and the associations between these factors were sought.
RESULTS: Patients with crescentic proliferative GN had the highest intensity of elastase deposits. In this group of patients, elastase was present in the glomerular endothelium, as well as in the tubular epithelium and interstitium. Patients with a high intensity of elastase deposits within the glomerular endothelium and Bowman's capsule had significantly higher urinary excretion of elastase. Patients with interstitial, mesangial and perivascular elastase deposits had significantly higher serum creatinine than those without. Patients with elastase deposits in the glomerular endothelium and in the interstitium had insignificantly higher proteinuria than those without.
CONCLUSION: Our data provide morphological evidence of leukocyte elastase involvement in renal injury occurring in the course of primary idiopathic GN, in particular in the proliferative types.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17853021     DOI: 10.1080/00365590701430893

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  5 in total

Review 1.  Re-Examining Neutrophil Participation in GN.

Authors:  Dawn J Caster; David W Powell; Irina Miralda; Richard A Ward; Kenneth R McLeish
Journal:  J Am Soc Nephrol       Date:  2017-06-15       Impact factor: 10.121

2.  Neutrophil exocytosis induces podocyte cytoskeletal reorganization and proteinuria in experimental glomerulonephritis.

Authors:  Dawn J Caster; Erik A Korte; Min Tan; Michelle T Barati; Shweta Tandon; T Michael Creed; David J Salant; Jessica L Hata; Paul N Epstein; Hui Huang; David W Powell; Kenneth R McLeish
Journal:  Am J Physiol Renal Physiol       Date:  2018-05-23

Review 3.  Therapeutic targeting of neutrophil exocytosis.

Authors:  Sergio D Catz; Kenneth R McLeish
Journal:  J Leukoc Biol       Date:  2020-01-28       Impact factor: 4.962

Review 4.  Neutrophils: game changers in glomerulonephritis?

Authors:  Tanya N Mayadas; Florencia Rosetti; Thomas Ernandez; Sanjeev Sethi
Journal:  Trends Mol Med       Date:  2010-07-29       Impact factor: 11.951

5.  Subfractionation, characterization, and in-depth proteomic analysis of glomerular membrane vesicles in human urine.

Authors:  Marie C Hogan; Kenneth L Johnson; Roman M Zenka; M Cristine Charlesworth; Benjamin J Madden; Doug W Mahoney; Ann L Oberg; Bing Q Huang; Alexey A Leontovich; Lisa L Nesbitt; Jason L Bakeberg; Daniel J McCormick; H Robert Bergen; Christopher J Ward
Journal:  Kidney Int       Date:  2013-11-06       Impact factor: 10.612

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.